Jeff Szer

发表

Differences between graft product and donor side effects following bone marrow or stem cell donation

N. Schmitz, M. Beksac, A. Nagler, 2003, Bone Marrow Transplantation.

Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells

J. Szer, A. Grigg, R. Hoyt, 2000, Bone Marrow Transplantation.

J. Szer, J. Chapman, I. Nivison-Smith, 2013, Internal medicine journal.

Allogeneic hematopoietic stem cell donation—standardized assessment of donor outcome data: A consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT)

A. Gratwohl, M. Aljurf, J. Szer, 2013, Bone Marrow Transplantation.

Oral chronic graft‐versus‐host disease in Australia: clinical features and challenges in management

I. Kerridge, J. Szer, D. Ritchie, 2015, Internal medicine journal.

Oral chronic graft‐versus‐host disease in Australia: clinical features and challenges in management

Jeff Szer, K. Hull, Ian Kerridge, 2015, Internal medicine journal (Print).

Female genital tract graft-versus-host disease: incidence, risk factors and recommendations for management

J. Szer, D. Zantomio, Y. Panek-Hudson, 2006, Bone Marrow Transplantation.

Acute left ventricular failure following melphalan and fludarabine conditioning

J. Szer, J. Seymour, A. Grigg, 2001, Bone Marrow Transplantation.

The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia

Erinna F. Lee, W. D. Fairlie, J. Szer, 2009, Leukemia.

Fludarabine-based non-myeloablative chemotherapy followed by infusion of HLA-identical stem cells for relapsed leukaemia and lymphoma

J. Szer, J. Seymour, P. Bardy, 1999, Bone Marrow Transplantation.

Cyclosporin, methotrexate and prednisolone for graft-versus-host disease prophylaxis in allogeneic peripheral blood progenitor cell transplants

J. Szer, A. Roberts, D. Curtis, 2008, Bone Marrow Transplantation.

Design issues in a randomized controlled trial of a pre-emptive versus empiric antifungal strategy for invasive aspergillosis in patients with high-risk hematologic malignancies

T. Sorrell, J. Szer, A. Schwarer, 2011, Leukemia & lymphoma.

BCR/ABL amplification in chronic myelocytic leukemia blast crisis following imatinib mesylate administration.

L. Campbell, J. Szer, Crisoula Patsouris, 2002, Cancer genetics and cytogenetics.

Palifermin for the reduction of acute GVHD: a randomized, double-blind, placebo-controlled trial

J. Szer, E. Waller, G. Long, 2012, Bone Marrow Transplantation.

Variability in determination of body weight used for dosing busulphan and cyclophosphamide in adult patients: results of an international survey.

J. Szer, A. Grigg, M. H. Harun, 1997, Leukemia & lymphoma.

Harvesting haemopoietic stem cells for future use: rainy days, real or imagined?

Jeff Szer, 2008, Internal medicine journal (Print).

Early cyclosporine taper in high-risk sibling allogeneic bone marrow transplants

J. Szer, R. Abraham, P. Bardy, 1997, Bone Marrow Transplantation.

Risk factors for post-engraftment invasive aspergillosis in allogeneic stem cell transplantation

G. Byrnes, J. Szer, K. Thursky, 2004, Bone Marrow Transplantation.

Factors influencing the outcome of donor marrow transplantation in adults from less than ideal donors: experience from two Australian centres.

J. Szer, P. Bardy, A. Grigg, 1997, Australian and New Zealand journal of medicine.

Autologous hemopoietic stem cell transplantation: a possible cure for rheumatoid arthritis?

J. Szer, I. Wicks, H. Cooley, 1997, Arthritis and rheumatism.

Pre-transplant ferritin, albumin and haemoglobin are predictive of survival outcome independent of disease risk index following allogeneic stem cell transplantation

L. Chee, Jeff Szer, David Ritchie, 2017, Bone Marrow Transplantation.

Deep vein thrombosis in association with acute intravascular haemolysis in glucose‐6‐phosphate dehydrogenase deficiency: a unique case

E. Chew, Jeff Szer, Philip A. Thompson, 2013, Internal medicine journal.

Reproductive status in long-term bone marrow transplant survivors receiving busulfan-cyclophosphamide (120 mg/kg)

J. Szer, A. Grigg, R. McLachlan, 2000, Bone Marrow Transplantation.

A prospective multicenter trial of peripheral blood stem cell sibling allografts for acute myeloid leukemia in first complete remission using fludarabine-cyclophosphamide reduced intensity conditioning.

J. Szer, L. To, A. Roberts, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Recombinant activated factor VII in treatment of bleeding complications following hematopoietic stem cell transplantation

J. Szer, A. Bacigalupo, A. Bacigalupo, 2005, Journal of thrombosis and haemostasis : JTH.

A randomized, open-label, multicenter comparative study of the efficacy and safety of piperacillin-tazobactam and cefepime for the empirical treatment of febrile neutropenic episodes in patients with hematologic malignancies.

J. Szer, G. Noskin, S. Sanche, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hepatitis B serological changes following allogeneic bone marrow transplantation

J. Szer, J. Sasadeusz, M. Slavin, 2013, Transplant infectious disease : an official journal of the Transplantation Society.